MedTrace Logo

The Water-Blueberry Study

NCT00520871 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2007-08-27

No results posted yet for this study

Summary

We will study the effect of supplementation of 1 L blueberry juice to participants with at least one elevated cardiovasculat risk factor.

Conditions

Interventions

DRUG

Blueberry juice

Sponsors & Collaborators

  • Ullevaal University Hospital

    collaborator OTHER

  • University of Oslo

    lead OTHER

Principal Investigators

  • Rune Blomhoff, PhD · University of Oslo

  • Serena Tonstad, MD · Ullevaal University Hospital

  • Anette Karlsen, MSc · University of Oslo

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-03-31
Completion
2004-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00520871 on ClinicalTrials.gov